Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Dividends Paid - Common and Preferred (2009)

Updated

Analysis

Elite Pharmaceuticals (ELTP) Dividends Paid - Common and Preferred (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 1.54 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 3.23 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 3.07 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.10 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -8.24 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 1.36 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.04 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.45 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2009 -36,800.00
API Access

Elite Pharmaceuticals Dividends Paid - Common and Preferred API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=ELTP&period=max&api_key=YOUR_API_KEY